Sympathoadrenal Axis in Hepatocellular Carcinoma Recurrence After Microwave Ablation: Mechanisms and Combination Therapy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2600127000

Enrollment

Unknown

Registered

2026-06-22

Start date

2026-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients diagnosed with liver cancer by pathology or clinical criteria

Interventions

Propranolol group:None

Control group:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who visited Harbin Medical University Cancer Hospital from January 2018 to June 2025; 2. Must be patients diagnosed with liver cancer by pathology or clinical criteria; 3. Those who undergo microwave ablation; 4. Have previously signed the "Informed Consent for Secondary Use of Medical History Data/Biological Specimens" of our hospital. 5. Good compliance and cooperation with follow-up.

Exclusion criteria

Exclusion criteria: 1. Inability to comply with the study protocol or procedures; 2. Patients who the investigator considers unsuitable for inclusion in this study.

Design outcomes

Primary

Measure	Time frame
Disease-Free Survival;	—

Secondary

Measure	Time frame
Overall survivial;Tumor recurrence time;	—

Countries

China

Contacts

Public ContactLi Shun

Harbin Medical University Cancer Hospital

lishun_bessie@163.com+86 451 86298975

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026